A federal judge has blocked on First Amendment grounds the Trump administration from asking job candidates at HHS and other agencies about their favorite Trump policies, saying there is “no legitimate ...

The Trump administration finalized updates to its Transparency in Coverage (TIC) rule Monday (Oct. 5), requiring health plans and insurers to publish more usable pricing data and attest to its ...

One behavioral health organization is cheering how the Trump administration wants states to root out fraud, waste and abuse in applied behavior analysis (ABA) services provided to Medicaid and CHIP ...

A new benchmark system designed to measure and track the structural fragility of the nation’s drug supply chain shows more than 550 million prescriptions were filled in 2023 for medicines with high or ...

Amid the Trump administration’s push to expand access to psychedelic drug therapies, FDA released a request for information Monday (Oct. 5) outlining for the first time how sponsors could safely ...

A new AARP report analyzes the tactics AstraZeneca used to prevent lower-cost alternatives to its blockbuster inhaler Symbicort from entering the market when the brand drug’s exclusivity period was ...

As several pharmacy benefit manager reform bills move through Congress, the top PBM lobby is leveraging a new government report to refute criticism that PBM-owned pharmacies under Medicare Part D ...

FDA’s push to find new members for its advisory committees could reshape the agency’s key panel that provides recommendations on vaccine approvals, adding up to 10 new members.

The much-anticipated final rule updating requirements for insurers and group health plans to publish negotiated prices has cleared the White House Office of Management and Budget.

CMS' latest guidance on determining a medically frail exemption from Medicaid work requirements may offer administrative relief to some stakeholders, but behavioral health advocates now worry that ...

Amid Eli Lilly’s expanding legal fight with compounders and online peptide sellers marketing its experimental weight-loss drug retatrutide, FDA has sent another tranche of warning letters to five ...

HHS Secretary Robert F. Kennedy Jr. told Senate health committee ranking member Bernie Sanders (I-VT) he’s willing to work together on legislation Sanders will soon introduce that would implement a ...